Literature DB >> 24125034

Postvaccination bullous pemphigoid in infancy: report of three new cases and literature review.

Sonia de la Fuente1, Ángela Hernández-Martín, Raúl de Lucas, Ma Antonia González-Enseñat, Asunción Vicente, Isabel Colmenero, María González-Beato, Mariona Suñol, Antonio Torrelo.   

Abstract

Bullous pemphigoid (BP) is an acquired autoimmune blistering disorder of unknown etiology uncommon in childhood. Unlike adult BP, infantile BP shows acral distribution and resolves rapidly with systemic steroids. We report three infants with infantile BP presenting shortly after vaccination for diphtheria, pertussis, tetanus, poliomyelitis, hepatitis B, Haemophilus influenzae B, and meningococcus C. Our cases further reinforce the causal association between childhood BP and vaccination.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24125034     DOI： 10.1111/pde.12231

Source DB:  PubMed          Journal:  Pediatr Dermatol        ISSN： 0736-8046            Impact factor:   1.588


  10 in total

Review 1.  Immune-mediated adverse reactions to vaccines.

Authors:  Cosby A Stone; Christine R F Rukasin; Thomas M Beachkofsky; Elizabeth J Phillips
Journal:  Br J Clin Pharmacol       Date:  2019-11-05       Impact factor: 4.335

2.  Recalcitrant infantile bullous pemphigoid successfully treated with cyclosporine.

Authors:  Efrat Bar-Ilan; Andrea Izabella Gál; Klára Veres; Anna Solti; Petra Ágnes Ferge; Tímea Dimény; Norbert Kiss; Zsuzsanna Szalai
Journal:  JAAD Case Rep       Date:  2022-09-13

Review 3.  Bullous Diseases in Children: A Review of Clinical Features and Treatment Options.

Authors:  Brittney Schultz; Kristen Hook
Journal:  Paediatr Drugs       Date:  2019-10       Impact factor: 3.022

4.  Bullous pemphigoid and COVID-19 vaccine.

Authors:  Israel Pérez-López; David Moyano-Bueno; Ricardo Ruiz-Villaverde
Journal:  Med Clin (Barc)       Date:  2021-05-27       Impact factor: 1.725

5.  Three case reports of post immunization and post viral Bullous Pemphigoid: looking for the right trigger.

Authors:  Luca Baroero; Paola Coppo; Laura Bertolino; Stefano Maccario; Francesco Savino
Journal:  BMC Pediatr       Date:  2017-02-23       Impact factor: 2.125

6.  Two infants with blistering rashes originating on acral sites as a presenting sign of infantile bullous pemphigoid.

Authors:  Brent Folsom; Tom Raisanen; Milad Eshaq
Journal:  JAAD Case Rep       Date:  2020-04-18

7.  Bullous Pemphigoid Associated With COVID-19 Vaccines: An Italian Multicentre Study.

Authors:  Carlo Alberto Maronese; Marzia Caproni; Chiara Moltrasio; Giovanni Genovese; Pamela Vezzoli; Paolo Sena; Giulia Previtali; Emanuele Cozzani; Giulia Gasparini; Aurora Parodi; Laura Atzori; Emiliano Antiga; Roberto Maglie; Francesco Moro; Elena Biancamaria Mariotti; Alberto Corrà; Sabatino Pallotta; Biagio Didona; Angelo Valerio Marzano; Giovanni Di Zenzo
Journal:  Front Med (Lausanne)       Date:  2022-02-28

Review 8.  Strategies to Improve Outcomes of Bullous Pemphigoid: A Comprehensive Review of Clinical Presentations, Diagnosis, and Patients' Assessment.

Authors:  Angelo Ruggiero; Matteo Megna; Alessia Villani; Rosita Comune; Gabriella Fabbrocini; Francesca di Vico
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-14

9.  Bullous pemphigoid following COVID-19 vaccine: An autoimmune disorder.

Authors:  Aneesh Rai; Govinda Khatri; Mohammad Mehedi Hasan
Journal:  Ann Med Surg (Lond)       Date:  2022-07-31

10.  Bullous pemphigoid in infants: characteristics, diagnosis and treatment.

Authors:  Agnes Schwieger-Briel; Cornelia Moellmann; Birgit Mattulat; Franziska Schauer; Dimitra Kiritsi; Enno Schmidt; Cassian Sitaru; Hagen Ott; Johannes S Kern
Journal:  Orphanet J Rare Dis       Date:  2014-12-10       Impact factor: 4.123
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.